Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00732810
First received: August 8, 2008
Last updated: August 25, 2014
Last verified: August 2014